Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials
Abstract Background Immunosuppressive agents have been widely used in the treatment of IgA nephropathy (IgAN), but the efficacy and safety remain controversial. The recent STOP-IgAN and TESTING studies have again focused attention on the application of immunosuppressive agents in IgAN. This study in...
Hlavní autoři: | , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMC
2019-08-01
|
Edice: | BMC Nephrology |
Témata: | |
On-line přístup: | http://link.springer.com/article/10.1186/s12882-019-1519-3 |